Tamoxifen Resistance and CYP2D6 Copy Numbers in Breast Cancer Patients

Motamedi, Sahar; Majidzadeh, Keivan; Mazaheri, Mahta; Anbiaie, Robab; Mortazavizadeh, Seyed Mohammad Reza; Esmaeili, Rezvan

추천

검색

자료유형: 학술저널

저자정보: Motamedi, Sahar (Science and Research Tehran Branch of Islamic Azad University) Majidzadeh, Keivan (Iranian Center for Breast Cancer [ICBC], Academic Center for Education, Culture and Research [ACECR]) Mazaheri, Mahta (Iranian Center for Breast Cancer [ICBC], Academic Center for Education, Culture and Research [ACECR]) Anbiaie, Robab (Iranian Center for Breast Cancer [ICBC], Academic Center for Education, Culture and Research [ACECR]) Mortazavizadeh, Seyed Mohammad Reza (Department of Oncology and Hematology, Shahid Sadoughi University of Medical Sciences) Esmaeili, Rezvan (Iranian Center for Breast Cancer [ICBC], Academic Center for Education, Culture and Research [ACECR])

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제13권 제12호

발행연도: 2012.1

수록면: 6,101 - 6,104 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Breast cancer accounts about one million from total annual ten million new diagnosed cases of neoplasia worldwide and is the main cause of death due to cancer in women. Tamoxifen is the most popular selective estrogen receptor modulator used in anti estrogen treatments. Tamoxifen must be converted into its metabolite endoxifen for biologic effects; this conversion process is catalysed by highly polymorphic cytochrome P450 2D6 (CYP2D6). This study surveyed copy number variation of the CYP2D6 gene and its possible correlation with Tamoxifen resistance in breast cancer patients. Methods: This case control study was performed on samples taken from 79 patients with breast cancer who used tamoxifen in Yazd and Tehran Cities, Iran. Real time reactions were conducted for 10 healthy samples using the comparative $C_t$ (Cycles threshold) method, each pair of genes being compared and samples with ratios around 1 were taken as control samples. Proliferation reactions were done by Real-Time PCR ABI Prism 7500. All registered data were transformed into SPSS 15 program and analyzed. Results: Efficiency of PCR for both CYP2D6 and ALB genes was 100%. From all 23 drug resistant patients 21.7% had one copy, 47.8% two copies and 30.4% had three copies. Also from all 56 drug sensitive patients, 26.8% had one copy, 51.8% two copies and 21.4% had three copies. The percentage of patients with one and two copies was similar between two groups but patients with three copies were more likely to belong to the drug resistant group more. Odd ratios for one and two copies were 0.759 and 0.853 respectively, indicating possible protective effects while that for three copies was 1.604. Conclusions: Based on our study there is no significant link between CYP2D6 gene copy numbers and tamoxifen resistance in women with breast cancer. But more studies considering other influencing factors appear warranted.

#Tamoxifen #CYP2D6 gene #copy numbers #drug resistance

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요